Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DxFLEX ClearLLab 10C US-IVD Clinical Study Protocol - Clinical Laboratory

NCT05467449 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT05467449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05467449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DxFLEX ClearLLab 10C US-IVD Clinical Study Protocol - Clinical Laboratory
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
April 12, 2022
Completion date
August 31, 2023
Enrollment
527 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hematological malignancy